Wynzora Topical Cream 60gm
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. It is essential to use this medication as directed.
Apply this medication only to your skin, as instructed by your doctor. Do not take it by mouth.
Avoid getting the medication in your mouth, nose, or eyes, as it may cause burning.
Do not apply the medication to your face, underarms, groin area, or skin that is thinning.
Do not insert the medication into your vagina.
Before and after applying the medication, wash your hands thoroughly. If you are treating a skin condition on your hand, do not wash your hand after application.
Application Instructions
Apply a thin layer of the medication to the affected skin area and gently rub it in.
Unless instructed by your doctor, do not cover the treated area with bandages, dressings, or makeup.
Storage and Disposal
Store the medication at room temperature, away from heat and light.
Keep the lid tightly closed and do not freeze the medication.
Missed Dose
If you miss a dose, apply it as soon as you remember.
If it is close to the time for your next dose, skip the missed dose and resume your regular schedule.
Do not apply two doses at the same time or use extra doses to make up for a missed dose.
Lifestyle & Tips
- Apply a thin layer to affected areas only, as directed by your doctor. Do not apply to the face, groin, or armpits, or if skin atrophy is present.
- Wash hands thoroughly after applying the cream, unless treating hands.
- Do not cover the treated area with bandages or other occlusive dressings unless directed by your doctor, as this can increase absorption.
- Avoid excessive exposure to natural or artificial sunlight (tanning beds, sunlamps) while using this medication, as calcipotriene can increase sensitivity to UV light.
- Do not use for longer than 8 weeks without consulting your doctor.
- Avoid contact with eyes, mouth, and other mucous membranes.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high calcium levels, including:
+ Weakness
+ Confusion
+ Feeling tired
+ Headache
+ Upset stomach and vomiting
+ Constipation
+ Bone pain
Signs of a weak adrenal gland, such as:
+ Severe upset stomach or vomiting
+ Severe dizziness or passing out
+ Muscle weakness
+ Feeling very tired
+ Mood changes
+ Decreased appetite
+ Weight loss
Signs of Cushing's syndrome, including:
+ Weight gain in the upper back or belly
+ Moon face
+ Severe headache
+ Slow healing
Signs of high blood sugar, such as:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Skin changes, including:
+ Pimples
+ Stretch marks
+ Slow healing
+ Hair growth
Irritation where the medication was applied
Skin breakdown where the medication is used
Change in skin color
Change in eyesight
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:
Itching
Signs of a common cold
* Headache
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Increased skin irritation, redness, burning, or itching at the application site.
- Signs of skin thinning, such as easy bruising, stretch marks (striae), or spider veins (telangiectasias).
- Signs of systemic steroid absorption: unusual weight gain, swelling in ankles/feet, increased thirst/urination, muscle weakness, fatigue, mood changes.
- Signs of high calcium levels (hypercalcemia): nausea, vomiting, constipation, muscle weakness, confusion, excessive thirst, increased urination.
- Any signs of infection at the application site (pus, worsening redness, fever).
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you have elevated calcium levels in your blood.
If you are currently experiencing a skin infection.
If the skin area where you will be applying this medication is thinning.
This list is not exhaustive, and it is crucial to discuss all your medications (including prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health issues. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
Before using any other medications or skin products, including soaps, consult with your doctor to ensure safe use. If you are undergoing light therapy, notify your doctor to avoid any potential interactions.
When applying this medication, avoid putting it on cuts, scrapes, or damaged skin. Exercise caution when applying it to large areas of skin or near open wounds, and consult with your doctor if you have any concerns.
To minimize the risk of severe side effects, adhere to your doctor's instructions regarding dosage and frequency of application. Do not exceed the recommended amount or use it for an extended period beyond what your doctor has prescribed.
As this medication may increase your susceptibility to sunburn, take precautions to protect your skin from the sun, sunlamps, and tanning beds. Use sunscreen and wear protective clothing and eyewear to minimize your risk.
Long-term use of this medication may increase the risk of developing cataracts or glaucoma. Discuss this potential risk with your doctor.
This medication is not approved for use in children, so it is crucial to consult with your doctor if you have any questions or concerns.
If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor to discuss the potential benefits and risks to you and your baby. When breastfeeding, avoid applying this medication directly to the nipple or surrounding area to prevent any potential harm to your baby.
Overdose Information
Overdose Symptoms:
- Excessive systemic absorption of calcipotriene can lead to hypercalcemia (high blood calcium levels), characterized by nausea, vomiting, constipation, muscle weakness, confusion, and increased urination.
- Excessive systemic absorption of betamethasone can lead to Cushing's syndrome (moon face, buffalo hump, central obesity, skin thinning, easy bruising) and HPA axis suppression (fatigue, weakness, nausea, vomiting, low blood pressure).
What to Do:
Discontinue use and seek immediate medical attention. Symptomatic and supportive treatment should be initiated. For hypercalcemia, hydration and calcium-lowering measures may be necessary. For HPA axis suppression, gradual withdrawal of the corticosteroid may be required. Call 1-800-222-1222 for poison control.
Drug Interactions
Moderate Interactions
- Other topical corticosteroids (increased risk of HPA axis suppression)
- Other topical vitamin D analogs (increased risk of hypercalcemia)
Monitoring
Baseline Monitoring
Rationale: To establish baseline for efficacy assessment.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Periodically, especially with extensive or prolonged use.
Target: Not applicable
Action Threshold: If suspected, perform ACTH stimulation test or plasma cortisol levels. Discontinue drug if confirmed.
Frequency: Periodically, especially with extensive or prolonged use.
Target: Not applicable
Action Threshold: If suspected, check serum calcium levels. Discontinue drug if confirmed.
Frequency: At each follow-up visit.
Target: Not applicable
Action Threshold: If severe or persistent, discontinue use.
Symptom Monitoring
- Skin irritation, redness, burning, itching
- Skin thinning, striae, telangiectasias
- Acne-like eruptions
- Folliculitis
- Signs of systemic corticosteroid absorption (e.g., weight gain, moon face, easy bruising, fatigue)
- Signs of hypercalcemia (e.g., nausea, vomiting, constipation, muscle weakness, confusion)
Special Patient Groups
Pregnancy
Category C. Use only if the potential benefit justifies the potential risk to the fetus. Animal studies have shown teratogenic effects with both calcipotriene and betamethasone.
Trimester-Specific Risks:
Lactation
Caution is advised. It is not known whether calcipotriene or betamethasone are excreted in human milk following topical application. Systemic absorption is limited, but potential for infant exposure exists. Avoid applying to areas that may come into direct contact with the infant's skin or mouth.
Pediatric Use
Safety and efficacy have not been established in pediatric patients under 18 years of age. Pediatric patients may be more susceptible to systemic toxicity from topical corticosteroids and calcipotriene due to a larger skin surface area to body weight ratio and immature skin barrier function, leading to increased systemic absorption. Risk of HPA axis suppression and hypercalcemia is higher.
Geriatric Use
No overall differences in safety or effectiveness were observed between elderly subjects and younger subjects. However, caution should be exercised in elderly patients who may have thinner skin or comorbidities that increase susceptibility to systemic effects.
Clinical Information
Clinical Pearls
- Wynzora is a fixed-dose combination, offering convenience and potentially improved adherence compared to separate applications.
- It is designed for once-daily application, which can improve patient compliance.
- The cream formulation may be preferred for dry, scaly lesions.
- Advise patients to use the smallest amount necessary to cover the affected areas and to avoid applying to healthy skin.
- Patients should be educated on the signs of HPA axis suppression and hypercalcemia, especially if using on large body surface areas or for prolonged periods.
- Not for use on the face, groin, or axillae due to increased risk of local adverse effects (e.g., skin atrophy) in these sensitive areas.
- Rebound phenomenon (worsening of psoriasis after discontinuation) can occur with topical corticosteroids; gradual tapering may be considered for prolonged use, though not explicitly stated for this product.
Alternative Therapies
- Topical corticosteroids (e.g., clobetasol, fluocinonide)
- Topical vitamin D analogs (e.g., calcipotriene, calcitriol)
- Topical retinoids (e.g., tazarotene)
- Topical calcineurin inhibitors (e.g., tacrolimus, pimecrolimus - off-label for psoriasis)
- Systemic therapies (e.g., methotrexate, cyclosporine, biologics, oral small molecules) for moderate to severe psoriasis
- Phototherapy (UVB, PUVA)